Browsing Tag
pharmaceutical acquisition
21 posts
Merck announces acquisition of Cidara Therapeutics in bid to strengthen its infectious disease portfolio
Find out how Merck’s acquisition of Cidara Therapeutics could reshape long-acting influenza prevention and expand the company’s infectious disease pipeline.
Merck to acquire Verona Pharma for $10bn, securing Ohtuvayre COPD therapy
Verona Pharma stock jumps 20% as Merck announces $10B acquisition to boost its COPD pipeline with first-in-class therapy Ohtuvayre. Read full analysis.
Granules India to acquire Senn Chemicals to expand CDMO business
Granules India Limited (BSE: 532482, NSE: GRANULES) has announced a strategic acquisition of Senn Chemicals AG, a Switzerland-based…
Cosette Pharmaceuticals to acquire Mayne Pharma in $430m deal, strengthening women’s health and dermatology portfolio
Cosette Pharmaceuticals has announced a definitive agreement to acquire Mayne Pharma Group Limited, a move that will significantly…
AbbVie to expand immunology pipeline with Nimble Therapeutics acquisition
In a significant move to solidify its presence in immunology, AbbVie has announced the acquisition of Nimble Therapeutics,…
Huge pharmaceutical deal: Platinum Equity gains control of Inventia Healthcare’s key division
In a significant move within the global pharmaceutical sector, Platinum Equity has secured a controlling stake in the…
Nestlé Health Science to acquire VOWST assets from Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) has announced a significant development in its partnership with Nestlé Health Science—a non-binding…
Cycle Pharmaceuticals proposes $466m acquisition of Vanda Pharmaceuticals
In a significant development within the pharmaceutical industry, UK-based Cycle Pharmaceuticals has offered to acquire Nasdaq-listed Vanda Pharmaceuticals…
Jazz Pharmaceuticals to acquire GW Pharmaceuticals in $7.2bn deal
In a significant move within the pharmaceutical industry, Irish biopharma company Jazz Pharmaceuticals has announced an agreement to…
Nordic Capital proposes $846m acquisition of Advanz Pharma
In a significant move within the pharmaceutical industry, Nordic Capital has made a formal offer to acquire Advanz…